COURTNEY NICKLES: Open Payments
NPI 1972269488 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,955 in 89 payments from 22 companies in 2025. Trend: 2023 $2,593 · 2024 $1,675 · 2025 $1,955
Food & beverage: $1,800Education: $155
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 28 | $408 |
| AstraZeneca Pharmaceuticals LP | 9 | $377 |
| Actelion Pharmaceuticals US, Inc. | 4 | $163 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $144 |
| HARMONY BIOSCIENCES LLC | 7 | $139 |
| Axsome Therapeutics, Inc. | 3 | $75 |
| GENZYME CORPORATION | 3 | $74 |
| United Therapeutics Corporation | 4 | $74 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
| Merck Sharp & Dohme LLC | 3 | $63 |
Products named: NUCALA, OPSUMIT, DUPIXENT, TRELEGY ELLIPTA, FASENRA, BREZTRI, OFEV, TEZSPIRE.
Industry payments across IN — which companies pay providers there.
